We measured copy number changes at DLK1 and both DMRs in the chromosomal region 14q32.2 by qPCR in bladder cancer tissues and cell lines to assess whether gene deletions were responsible for the decreased expression of the two genes in urothelial carcinoma (Figure 3). This evidence concerns the gene DLK1 and urinary bladder cancer.